Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Inhibition of human leukemia xenograft in nude mice by adenovirus-mediated tissue inhibitor of metalloproteinase-3

Leukemia volume 20, pages 1–8 (2006)Cite this article

Abstract

Considerable studies have demonstrated the pivotal roles of matrix metalloproteinases (MMPs) in leukemia dissemination and extramedullary infiltration. Tissue inhibitors of matrix metalloproteinases (TIMPs) are multifunctional proteins with MMPs inhibitory effects. However, little is known about the application of TIMPs in the treatment of leukemia. Here, we investigated the effects of TIMP-3 overexpression via adenoviral gene delivery on the in vitro growth and invasiveness of leukemic cells and the in vivo progress of K562-derived xenografts in nude mice. The in vitro invasiveness of K562 cells was markedly impaired by AdTIMP-3 infection. Moreover, TIMP-3 significantly inhibited K562-derived angiogenic factors-induced proliferation, migration and bFGF-induced tube formation of endothelial cells (ECs) in vitro, and reduced VEGF-induced gelatinases expression and activation in ECs. Although TIMP-3 overexpression had no direct effect on the growth of K562 cells in vitro, repeated intratumoral injection of AdTIMP-3 significantly inhibited the growth of K562 xenografts in nude mice. Furthermore, lower microvessel density, less vessel maturity and increased apoptosis were observed in AdTIMP-3-treated K562 xenografts, suggesting the importance of antiangiogenic action of TIMP-3. These data demonstrated the potential of applying AdTIMP-3 as an effective antiangiogenic adjuvant in the treatment of leukemia progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 3
Figure 1
Figure 2
Figure 4

Similar content being viewed by others

References

  1. John A, Tuszynski G . The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 2001; 7: 14–23.

    Article  CAS  PubMed  Google Scholar 

  2. Hidalgo M, Eckhardt SG . Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst 2001; 93: 178–193.

    Article  CAS  PubMed  Google Scholar 

  3. Brand K . Cancer gene therapy with tissue inhibitors of metalloproteinases (TIMPs). Curr Gene Ther 2002; 2: 255–271.

    Article  CAS  PubMed  Google Scholar 

  4. Freireich EJ . Acute leukemia. A prototype of disseminated cancer. Cancer 1984; 53: 2026–2033.

    Article  CAS  PubMed  Google Scholar 

  5. Sawyers CL, Denny CT, Witte ON . Leukemia and the disruption of normal hematopoiesis. Cell 1991; 64: 337–350.

    Article  CAS  PubMed  Google Scholar 

  6. Guedez L, Lim MS, Stetler-Stevenson WG . The role of metalloproteinases and their inhibitors in hematological disorders. Crit Rev Oncog 1996; 7: 205–225.

    Article  CAS  PubMed  Google Scholar 

  7. Baker AH, George SJ, Zaltsman AB, Murphy G, Newby AC . Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. Br J Cancer 1999; 79: 1347–1355.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Ahonen M, Ala-Aho R, Baker AH, George SJ, Grenman R, Saarialho-Kere U et al. Antitumor activity and bystander effect of adenovirally delivered tissue inhibitor of metalloproteinases-3. Mol Ther 2002; 5: 705–715.

    Article  CAS  PubMed  Google Scholar 

  9. Spurbeck WW, Ng CY, Strom TS, Vanin EF, Davidoff AM . Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model. Blood 2002; 100: 3361–3368.

    Article  CAS  PubMed  Google Scholar 

  10. Tran PL, Vigneron JP, Pericat D, Dubois S, Cazals D, Hervy M et al. Gene therapy for hepatocellular carcinoma using non-viral vectors composed of bis guanidinium-tren-cholesterol and plasmids encoding the tissue inhibitors of metalloproteinases TIMP-2 and TIMP-3. Cancer Gene Ther 2003; 10: 435–444.

    Article  CAS  PubMed  Google Scholar 

  11. Ma DH, Chen JI, Zhang F, Hwang DG, Chen JK . Inhibition of fibroblast-induced angiogenic phenotype of cultured endothelial cells by the overexpression of tissue inhibitor of metalloproteinase (TIMP)-3. J Biomed Sci 2003; 10: 526–534.

    Article  CAS  PubMed  Google Scholar 

  12. Baker AH, Zaltsman AB, George SJ, Newby AC . Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J Clin Invest 1998; 101: 1478–1487.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Bond M, Murphy G, Bennett MR, Amour A, Knäuper V, Newby AC et al. Localization of the death domain of tissue inhibitor of metalloproteinase-3 to the N terminus: metalloproteinase inhibition is associated with proapoptotic activity. J Biol Chem 2000; 275: 41358–41363.

    Article  CAS  PubMed  Google Scholar 

  14. Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ et al. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 1998; 435: 39–44.

    Article  CAS  PubMed  Google Scholar 

  15. Wild A, Ramaswamy A, Langer P, Celik I, Fendrich V, Chaloupka B et al. Frequent methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene in pancreatic endocrine tumors. J Clin Endocrinol Metab 2003; 88: 1367–1373.

    Article  CAS  PubMed  Google Scholar 

  16. Dias S, Hattori K, Zhu Z, Heissig B, Choy M, Lane W et al. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J Clin Invest 2000; 106: 511–521.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Lynch CC, McDonnell S . The role of matrilysin (MMP-7) in leukaemia cell invasion. Clin Exp Metast 2001; 18: 401–406.

    Article  Google Scholar 

  18. Weidner N, Semple JP, Welch WR, Folkman J . Tumor angiogenesis and metastasis – correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1–8.

    Article  CAS  PubMed  Google Scholar 

  19. Etoh T, Inoue H, Tanaka S, Barnard GF, Kitano S, Mori M . Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. Cancer Res 2001; 61: 2145–2153.

    CAS  PubMed  Google Scholar 

  20. Moses MA . The regulation of neovascularization of matrix metalloproteinases and their inhibitors. Stem Cells 1997; 15: 180–189.

    Article  CAS  PubMed  Google Scholar 

  21. Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000; 96: 2240–2245.

    CAS  PubMed  Google Scholar 

  22. Ahonen M, Poukkula M, Baker AH, Kashiwagi M, Nagase H, Eriksson JE et al. Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors. Oncogene 2003; 22: 2121–2134.

    Article  CAS  PubMed  Google Scholar 

  23. Qi JH, Ebrahem Q, Moore N, Murphy G, Claesson-Welsh L, Bond M et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 2003; 9: 407–415.

    Article  CAS  PubMed  Google Scholar 

  24. Liuzzo JP, Moscatelli D . Human leukemia cell lines bind basic fibroblast growth factor (FGF) on FGF receptors and heparan sulfates: downmodulation of FGF receptors by phorbol ester. Blood 1996; 87: 245–255.

    CAS  PubMed  Google Scholar 

  25. Nakamura Y, Sato K, Wakimoto N, Kimura F, Okuyama A, Motoyoshi K . A new matrix metalloproteinase inhibitor SI-27 induces apoptosis in several human myeloid leukemia cell lines and enhances sensitivity to TNF alpha-induced apoptosis. Leukemia 2001; 15: 1217–1224.

    Article  CAS  PubMed  Google Scholar 

  26. Narla RK, Dong Y, Klis D, Uckun FM . Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium (I.V.) as a novel antileukemic agent with matrix metalloproteinase inhibitory activity. Clin Cancer Res 2001; 7: 1094–1101.

    CAS  PubMed  Google Scholar 

  27. Wierda WG, Cantwell MJ, Woods SJ, Rassenti LZ, Prussak CE, Kipps TJ . CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia. Blood 2000; 96: 2917–2924.

    CAS  PubMed  Google Scholar 

  28. Liu P, Wang Y, Li YH, Yang C, Zhou YL, Li B et al. Adenovirus-mediated gene therapy with an antiangiogenic fragment of thrombospondin-1 inhibits human leukemia xenograft growth in nude mice. Leuk Res 2003; 27: 701–708.

    Article  CAS  PubMed  Google Scholar 

  29. Nilsson M, Ljungberg J, Richter J, Kiefer T, Magnusson M, Lieber A et al. Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells. J Gene Med 2004; 6: 631–641.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the grants of National Development Plan of High Technology 863 (2003AA205060) and 973 (001CB5101) projects from the Ministry of Science & Technology of China to Han ZC.

Author information

Authors and Affiliations

  1. State Key Laboratory of Experimental Hematology, Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

    X F Yu, L H Liang, B Liu, B Zhou, B Li & Z C Han

  2. National Engineering Research Center of Cell Products, AmCellGene Co. Ltd, TEDA, Tianjin, People's Republic of China

    C Yang & Z C Han

Authors
  1. X F Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L H Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Z C Han
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Z C Han.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, X., Yang, C., Liang, L. et al. Inhibition of human leukemia xenograft in nude mice by adenovirus-mediated tissue inhibitor of metalloproteinase-3. Leukemia 20, 1–8 (2006). https://doi.org/10.1038/sj.leu.2404021

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404021

Keywords

This article is cited by

Search

Advanced search

Quick links